ET-09 ACQUIRED MALIGNANT BEHAVIORS OF NPE6-PDT-SURVIVED GLIOBLASTOMA CELLS ARE SUPPRESSED BY USING MEK1/2 INHIBITOR TRAMETINIB

INTRODUCTION: In this study, we tried to investigate alteration of oncogenic properties and their molecular regulatory mechanism of talaporfin sodium (NPe6)-mediated photodynamic therapy (NPe6-PDT)-survived glioblastoma (GBM) cells. METHODS: As the in-vitro NPe6-PDT model, human GBM cell lines (T98G...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurooncol Adv
Asıl Yazarlar: Kobayashi, Tatsuya, Muragaki, Yoshihiro, Takahashi, Masamichi, Wada, Kojiro, Mori, Kentaro, Kawamata, Takakazu, Ichimura, Koichi, Tomiyama, Arata
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213242/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.040
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller